Editorial
doi: 10.1136/thx.53.1.1.
Long acting beta 2 agonists and the risk of life threatening asthma
- PMID: 9577513
- PMCID: PMC1758694
- DOI: 10.1136/thx.53.1.1
Item in Clipboard
Editorial
Long acting beta 2 agonists and the risk of life threatening asthma
Thorax.
1998 Jan.
No abstract available
Comment on
-
Case-control study of salmeterol and near-fatal attacks of asthma.Thorax. 1998 Jan;53(1):7-13. doi: 10.1136/thx.53.1.7. Thorax. 1998. PMID: 9577515 Free PMC article.
Similar articles
-
Asthma mortality and beta-agonists.Chest. 1995 Dec;108(6):1768. doi: 10.1378/chest.108.6.1768. Chest. 1995. PMID: 7497807 No abstract available.
-
Case-control study of salmeterol and near-fatal attacks of asthma.Thorax. 1998 Jan;53(1):7-13. doi: 10.1136/thx.53.1.7. Thorax. 1998. PMID: 9577515 Free PMC article.
-
Evidence based answers--is salmeterol safe in asthma?Aust Fam Physician. 2006 Aug;35(8):625-6. Aust Fam Physician. 2006. PMID: 16894440 No abstract available.
-
Salmeterol (Serevent) asthma trial halted early.CMAJ. 2003 Mar 18;168(6):738. CMAJ. 2003. PMID: 12642431 Free PMC article. Review. No abstract available.
-
Are there any detrimental effects of the use of inhaled long-acting beta 2-agonists in the treatment of asthma?Chest. 1995 Apr;107(4):1116-24. doi: 10.1378/chest.107.4.1116. Chest. 1995. PMID: 7705125 Review. No abstract available.
Cited by
-
[Risk factor "smoking" : smoking cessation in patients with cardiovascular diseases].Internist (Berl). 2012 Jan;53(1):45-50. doi: 10.1007/s00108-011-2892-6. Internist (Berl). 2012. PMID: 22146935 German.
